May 2, 2019 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/ grants-contracts/funding-news- notices
Feature Articles
Misunderstanding how the term "unsolicited" applies to funding opportunity announcements may result in your failing to meet our requirements for big grants.
Opportunities and Resources
Through a broad funding opportunity announcement, NIAID will support research on preventing tickborne diseases using novel or established approaches.
Apply to conduct innovative basic science that can lead to discovering or characterizing novel biologically active viral or host RNAs involved in virology (including HIV biology) and immune regulation.
Conduct biomarker discovery activities that will lead to non-sputum-based tuberculosis diagnostics for use in HIV-1-infected and HIV-1-exposed uninfected children in decentralized settings.
Apply for funding to accelerate the development and validation of sample sparing assays that can be applied for studying the human immune system in health and disease.
In The News
The template will help you succinctly communicate the science, methods, and operations of clinical trials, specifically for trials involving behavioral or social interventions.
Advice Corner
Read our guidance to determine the likely budget cap on your next investigator-initiated small business grant application.
Reader Questions
New Funding Opportunities
- RFA-AI-19-045, HIV/AIDS Clinical Trials Units (UM1, Clinical Trial Required)
- PAR-19-262, Lasker Clinical Research Scholars Program (Si2/R00, Clinical Trial Optional)
- RFP NIAID-DAIT-NIHAI201800019, Radiation/Nuclear Medical Countermeasure Product Development Support
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
No hay comentarios:
Publicar un comentario